These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin. Mura P; Faucci MT; Bettinetti GP Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903 [TBL] [Abstract][Full Text] [Related]
43. Encapsulation of gallic acid/cyclodextrin inclusion complex in electrospun polylactic acid nanofibers: Release behavior and antioxidant activity of gallic acid. Aytac Z; Kusku SI; Durgun E; Uyar T Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():231-9. PubMed ID: 27040215 [TBL] [Abstract][Full Text] [Related]
44. Solubility and stability of melatonin in propylene glycol and 2-hydroxypropyl-beta-cyclodextrin vehicles. Lee BJ; Choi HG; Kim CK; Parrott KA; Ayres JW; Sack RL Arch Pharm Res; 1997 Dec; 20(6):560-5. PubMed ID: 18982260 [TBL] [Abstract][Full Text] [Related]
45. Effect of hydroxypropyl-β-cyclodextrin and coadjuvants on the sorption capacity of hydrophilic polymer films for monoterpene alcohols. Higueras L; López-Carballo G; Gavara R; Hernández-Muñoz P Carbohydr Polym; 2016 Oct; 151():1193-1202. PubMed ID: 27474670 [TBL] [Abstract][Full Text] [Related]
46. Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin. Williams RO; Mahaguna V; Sriwongjanya M Eur J Pharm Biopharm; 1998 Nov; 46(3):355-60. PubMed ID: 9885309 [TBL] [Abstract][Full Text] [Related]
48. Effect of hydroxypropyl-beta-cyclodextrin and pH on the solubility of levemopamil HCl. McCandless R; Yalkowsky SH J Pharm Sci; 1998 Dec; 87(12):1639-42. PubMed ID: 10189280 [TBL] [Abstract][Full Text] [Related]
49. Diloxanide furoate binary complexes with β-, methyl-β-, and hydroxypropyl-β-cyclodextrins: inclusion mode, characterization in solution and in solid state and in vitro dissolution studies. Aloisio C; Longhi M Pharm Dev Technol; 2018 Sep; 23(7):723-731. PubMed ID: 28758845 [TBL] [Abstract][Full Text] [Related]
50. Mechanistic studies of the effect of hydroxypropyl-beta-cyclodextrin on in vitro transdermal permeation of corticosterone through hairless mouse skin. Shaker DS; Ghanem AH; Li SK; Warner KS; Hashem FM; Higuchi WI Int J Pharm; 2003 Mar; 253(1-2):1-11. PubMed ID: 12593932 [TBL] [Abstract][Full Text] [Related]
51. Drug/cyclodextrin solid systems in the design of hydrophilic matrices: a strategy to modulate drug delivery rate. Miro A; Quaglia F; Giannini L; Cappello B; La Rotonda MI Curr Drug Deliv; 2006 Oct; 3(4):373-8. PubMed ID: 17076639 [TBL] [Abstract][Full Text] [Related]
52. Sublingual insulin administration: application of hydroxypropyl beta-cyclodextrin and poloxamer188 as permeation enhancers. Paprikar A; Soni A; Kaushal N; Lin S Pharm Dev Technol; 2021 Feb; 26(2):233-242. PubMed ID: 33258391 [TBL] [Abstract][Full Text] [Related]
53. Is 2-Hydroxypropyl-β-cyclodextrin a Suitable Carrier for Central Administration of Δ Agabio R; Sanna F; Lobina C; Monduzzi M; Nairi V; Cugia F; Mameli S; Pisanu GM; Gessa GL; Melis MR Drug Dev Res; 2017 Dec; 78(8):411-419. PubMed ID: 28921601 [TBL] [Abstract][Full Text] [Related]
54. Effect of cyclodextrin complexation on the liposome permeability of a model hydrophobic weak Acid. Joguparthi V; Anderson BD Pharm Res; 2008 Nov; 25(11):2505-15. PubMed ID: 18642063 [TBL] [Abstract][Full Text] [Related]
55. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Jug M; Bećirević-Laćan M Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497 [TBL] [Abstract][Full Text] [Related]
56. Supramolecular system of podophyllotoxin and hydroxypropyl-β-cyclodextrin: Characterization, inclusion mode, docking calculation, solubilization, stability and cytotoxic activity. Yang LJ; Wang SH; Zhou SY; Zhao F; Chang Q; Li MY; Chen W; Yang XD Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():1136-1145. PubMed ID: 28482478 [TBL] [Abstract][Full Text] [Related]
57. Intracorneal melatonin delivery using 2-hydroxypropyl-β-cyclodextrin ophthalmic solution for granular corneal dystrophy type 2. Ahn JH; Kim HD; Abuzar SM; Lee JY; Jin SE; Kim EK; Hwang SJ Int J Pharm; 2017 Aug; 529(1-2):608-616. PubMed ID: 28694094 [TBL] [Abstract][Full Text] [Related]
58. Characterization, in Vitro and in Vivo Evaluation of Naringenin-Hydroxypropyl-ß-Cyclodextrin Inclusion for Pulmonary Delivery. Guan M; Shi R; Zheng Y; Zeng X; Fan W; Wang Y; Su W Molecules; 2020 Jan; 25(3):. PubMed ID: 32012911 [TBL] [Abstract][Full Text] [Related]
59. Polymer-free electrospun nanofibers from sulfobutyl ether Yildiz ZI; Celebioglu A; Uyar T Int J Pharm; 2017 Oct; 531(2):550-558. PubMed ID: 28445768 [TBL] [Abstract][Full Text] [Related]
60. Delay in ICR/f rat lens opacification by the instillation of eye drops containing disulfiram and hydroxypropyl-beta-cyclodextrin inclusion complex. Nagai N; Takeda M; Ito Y; Takeuchi N; Kamei A Biol Pharm Bull; 2007 Aug; 30(8):1529-34. PubMed ID: 17666815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]